Patent holdings for IPC class C12N 15/45

Total number of patents in this class: 175

10-year publication summary

2
2
2
4
6
4
8
6
21
17
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The United States of America, as represented by the Secretary, Department of Health and Human Services
2919
5
Glaxosmithkline Biologicals S.A.
1647
4
Icahn School of Medicine at Mount Sinai
979
4
Intervet International B.V.
1300
4
Boehringer Ingelheim Vetmedica GmbH
1277
3
Centre National de La Recherche Scientifique
10716
3
ID Pharma Co., Ltd.
42
3
The Research Foundation for Microbial Diseases of Osaka University
67
3
The University of Tokyo
4252
3
Beijing Cell-fusion Biotechnology Co., Ltd.
6
3
Shanghai King-cell Biotechnology Co. Ltd.
6
3
Shenzhen Rhegen Biotechnology Co., Ltd.
41
3
Wuhan Rhegen Biotechnology Co., Ltd.
32
3
Mayo Foundation for Medical Education and Research
3295
2
Children's Healthcare of Atlanta, Inc.
250
2
Cornell University
3365
2
Emory University
1666
2
Institute of Microbiology, Chinese Academy of Sciences
123
2
Merial Limited
111
2
Pontificia Universidad Catolica de Chile
301
2
Other owners 117